Correction to: FLEND (nelarabine, fludarabine, and etoposide) for relapsed T-cell acute lymphoblastic leukemia in children: a report from Japan Children's Cancer Group.

Correction to: FLEND (nelarabine, fludarabine, and etoposide) for relapsed T-cell acute lymphoblastic leukemia in children: a report from Japan Children's Cancer Group. Int J Hematol. 2021 Jan 23;: Authors: Kumamoto T, Goto H, Ogawa C, Hori T, Deguchi T, Araki T, Saito AM, Manabe A, Horibe K, Toyoda H PMID: 33484418 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/33484418?dopt=Abstract

Source: International Journal of Hematology - January 23, 2021 Category: Hematology Authors: Kumamoto T, Goto H, Ogawa C, Hori T, Deguchi T, Araki T, Saito AM, Manabe A, Horibe K, Toyoda H Tags: Int J Hematol Source Type: research